Article Versions Notes

Abedellatif S-E, Hosni R, Waha A, Gielen GH, Banat M, Hamed M, Güresir E, Fröhlich A, Sirokay J, Wulf A-L, et al. Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening. Pharmaceutics. 2024; 16(8):1042. https://doi.org/10.3390/pharmaceutics16081042

Abedellatif, Saif-Eldin, Racha Hosni, Andreas Waha, Gerrit H. Gielen, Mohammed Banat, Motaz Hamed, Erdem Güresir, Anne Fröhlich, Judith Sirokay, Anna-Lena Wulf, and et al. 2024. "Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening" Pharmaceutics 16, no. 8: 1042. https://doi.org/10.3390/pharmaceutics16081042

Abedellatif, S.-E., Hosni, R., Waha, A., Gielen, G. H., Banat, M., Hamed, M., Güresir, E., Fröhlich, A., Sirokay, J., Wulf, A.-L., Kristiansen, G., Pietsch, T., Vatter, H., Hölzel, M., Schneider, M., & Toma, M. I. (2024). Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening. Pharmaceutics, 16(8), 1042. https://doi.org/10.3390/pharmaceutics16081042